We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.50
Bid: 2.36
Ask: 2.46
Change: 0.02 (0.84%)
Spread: 0.10 (4.237%)
Open: 2.50
High: 2.50
Low: 2.50
Prev. Close: 2.39
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on announcement from Consortium

26 Apr 2021 09:00

RNS Number : 5657W
Globalworth Real Estate Inv Ltd
26 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

26 April 2021

Globalworth Real Estate Investments Limited ("Globalworth" or the "Company")

Update on announcement from CPI Property Group S.A. and Aroundtown SA (the "Consortium")

On 14 April 2021, CPI Property Group S.A. and Aroundtown SA unilaterally announced a firm intention to make a cash offer for the share capital of Globalworth not already owned or controlled by them at EUR 7.00 per Globalworth share (the "Offer").

On 19 April 2021, Globalworth announced the formation of an independent committee of the Board (the "Independent Committee") to evaluate the Offer.

The Independent Committee values both members of the Consortium as shareholders and supporters of the Company. However, having considered the Offer with its advisers, it has concluded that the Offer significantly undervalues the Company, its assets and its prospects.

The Offer price of EUR 7.00 per Globalworth share represents a significant discount to the Company's EPRA NAV, which will be updated and published as part of the offer process, which was EUR 8.68 per share as of 31 December 2020.

The Offer also represents a discount of more than 27% to the Company's 6-month volume weighted average price as of 21 February 2020, being the last date prior to the start of the COVID-19 pandemic.

Accordingly, the Independent Committee advises Globalworth shareholders to take no action in relation to this Offer which materially undervalues the Company.

The Independent Committee notes that the Consortium has not sought a recommendation for the Offer.

The Independent Committee will provide Globalworth shareholders with its formal response to the Offer following publication of the offer document by the Consortium. Further announcements will be made as and when appropriate.

Enquiries:

 

Globalworth

Tel: +40 372 800 000

Geoff Miller, Chair of the Board

J.P. Morgan Cazenove (Financial Adviser)

Tel: +44 20 7742 4000

Massimo Saletti / Leon Li

Dwayne Lysaght / Jonty Edwards

 

 

Jefferies (Joint Broker)

Tel: +44 20 7029 8000

Stuart Klein

Panmure Gordon (Nominated Adviser and Joint Broker)

Tel: +44 20 7886 2500

Dominic Morley / Alina Vaskina / Joanna Langley

 

 

Important notices

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this announcement in whole or in part in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

The person responsible for arranging for the release of this announcement on behalf of the Company is Nicola Marrin, Company Secretary.

Disclaimer

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Globalworth and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Globalworth for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.globalworth.com, by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPPPUPCCUPGUMQ
Date   Source Headline
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price
28th Mar 20247:00 amRNSScrip Dividend Share Reference Price
26th Mar 20249:41 amRNSBuy back of Shares into Treasury and TVR
22nd Mar 20244:06 pmRNSPublication of Annual Report and Date of AGM
12th Mar 20244:04 pmRNSInterim Dividend & Scrip Alternative
11th Mar 20243:48 pmRNSTransfer of shares out of treasury
11th Mar 20243:35 pmRNSPreliminary results FY23
11th Mar 20243:03 pmRNSSale of part of logistics portfolio
24th Nov 202312:34 pmRNSS&P - 'BB+' Rating affirmed
27th Sep 20237:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
19th Sep 20237:00 amRNSHalf-year Report
14th Sep 20237:00 amRNSScrip Dividend Share Reference Price
30th Aug 20237:00 amRNSInterim Dividend & Scrip Alternative
29th Aug 20233:43 pmRNSNotice of Interim Results & Prelim Interim Results
4th Jul 20237:00 amRNSInvestment grade rating maintained - Correction
3rd Jul 20236:19 pmRNSFitch investment grade credit rating maintained
27th Jun 20232:25 pmRNSResults of Tender Offers
20th Jun 20239:22 amRNSTender Offers Launch for 2025 Notes & 2026 Notes
19th Jun 202310:55 amRNSResult of AGM
8th Jun 20239:27 amRNSMoody's Ratings Action and Withdrawal
17th May 20237:00 amRNSAGM Notice & Availability of Annual Report
14th Apr 20233:52 pmRNSDirectorate Change
4th Apr 202312:33 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20231:29 pmRNSBuy back of Shares into Treasury & TVR
24th Mar 20237:00 amRNSPosting of Annual Report and Date of AGM
23rd Mar 20237:00 amRNSScrip Dividend Share Reference Price
22nd Mar 20234:53 pmRNSS&P Rating Action
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:10 pmRNSInterim Dividend & Scrip Alternative
8th Mar 202312:12 pmRNSTransfer of Shares out of Treasury
8th Mar 202311:59 amRNSResult of EGM
3rd Mar 20237:00 amRNSCondensed Unaudited Results for FY 31 Dec 2022
24th Feb 20234:44 pmRNSNotice of EGM
23rd Dec 202210:30 amRNSNew Financing Facilities with the Erste Group
19th Dec 20227:00 amRNSCarbon Emissions Reduction Commitment
21st Oct 20223:00 pmRNSCEO succession
20th Sep 20227:00 amRNSHalf-year Report
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:01 amRNSInterim Dividend Payment
31st Aug 20227:00 amRNSNotice of Interim Results & Prelim Interim Info
8th Jul 20227:00 amRNSStatement re stated post-offer intentions
21st Jun 202212:15 pmRNSRepayment of Bond
20th Jun 202210:36 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.